By Sarah Wong
Newswise — The beginning of the COVID-19 pandemic presented a huge challenge to healthcare workers. Doctors struggled to predict how different patients would fare under treatment against the novel SARS-CoV-2 virus. Deciding how to triage medical resources when presented with very little information took a mental and physical toll on caregivers as the pandemic progressed.
To ease this burden, researchers at Pacific Northwest National Laboratory (PNNL), Stanford University, Virginia Tech, and John Snow Labs developed TransMED, a first-of-its-kind artificial intelligence (AI) prediction tool aimed at addressing issues caused by emerging or rare diseases.
“As COVID-19 unfolded over 2020, it brought a number of us together into thinking how and where we could contribute meaningfully,” said chief scientist Sutanay Choudhury. “We decided we could make the most impact if we worked on the problem of predicting patient outcomes.”
“COVID presented a unique challenge,” said Khushbu Agarwal, lead author of the study published in Nature Scientific Reports. “We had very limited patient data for training an AI model that could learn the complex patterns underlying COVID patient trajectories.”
The multi-institutional team developed TransMED to address this challenge, analyzing data from existing diseases to predict outcomes of an emerging disease.
###
About PNNL
Pacific Northwest National Laboratory draws on its distinguishing strengths in chemistry, Earth sciences, biology and data science to advance scientific knowledge and address challenges in sustainable energy and national security. Founded in 1965, PNNL is operated by Battelle for the Department of Energy’s Office of Science, which is the single largest supporter of basic research in the physical sciences in the United States. DOE’s Office of Science is working to address some of the most pressing challenges of our time. For more information, visit https://energy.gov/science. For more information on PNNL, visit PNNL's News Center. Follow us on Twitter, Facebook, LinkedIn and Instagram.
MEDIA CONTACT
Register for reporter access to contact detailsArticle Multimedia

Credit: Composite image by Shannon Colson | Pacific Northwest National Laboratory
Caption: TransMED can help predict the outcomes of COVID-19 patients, generating predictions from different kinds of clinical data, including clinical notes, laboratory tests, diagnosis codes and prescribed drugs. The other uniqueness of TransMED lies in its ability to transfer learn from existing diseases to better predict and reason about progression of new and rare diseases.

Credit: Photo by Andrea Starr | Pacific Northwest National Laboratory
Caption: From left to right, PNNL researchers Robert Rallo, Sutanay Choudhury, Khushbu Agarwal, and Colby Ham helped develop TransMED.
CITATIONS
